Trial Profile
A retrospective cohort study to compare high statin monotherapy and statin plus ezetimibe combination therapy for reducing cardio-cerebrovascular disease risk.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Cerebrovascular disorders
- Focus Therapeutic Use
- 09 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.